関連する実験動画
Updated: Apr 15, 2026

10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
3.0K
構造生物学 構造生物学について CRISPR-Cmr複合体の構造は,RNAの標的の位置づけの方法を明らかにしています
David W Taylor1, Yifan Zhu2, Raymond H J Staals2
1Howard Hughes Medical Institute, University of California, Berkeley, CA 94720, USA. California Institute for Quantitative Biosciences, University of California, Berkeley, CA 94720, USA.
まとめ
バクテリアは,適応免疫のためにCRISPR-Casシステムを使用します. タイプIIIのCRISPR-Cas複合体は,Cmrのように,螺旋状のタンパク質の配置を使用して単一鎖RNAを標的とし,特定の間隔でそれを割ります.
科学分野:
- 分子生物学は分子生物学である.
- 微生物学 微生物学とは
- 構造生物学 構造生物学とは
背景:
- バクテリアは,外来核酸を標的としたCRISPR-Casシステムを通じて適応免疫を持っています.
- CRISPR-Casシステムはタイプに分類され,タイプIとIIはDNAを標的とし,タイプIIIはRNAを標的とする.
- Cmr複合体は,CRISPR-Cas監視複合体のタイプIIIである.
研究 の 目的:
- 国産のCmr複合体III型の近原子構造を解明する.
- タイプIIIのCRISPR-CasシステムによるRNA誘導監視のメカニズムを理解し,RNA分裂を標的とする.
主な方法:
- クリオ電子顕微鏡 (cryo-EM) を使用して,原子に近い解像度の再構築を生成しました.
- ネイティブCmr複合体は,標的RNAの存在と欠如の両方で研究されました.
主要な成果:
- Cmr複合体は螺旋状のタンパク質配列を採用し,crRNA媒介の標的RNA結合を促進します.
- 複合体内の親指のようなβヘアピンが,6核酸間隔で標的RNAを分裂するのに不可欠です.
- タイプIIIのCmr複合体とタイプIのCRISPR-Cascade複合体の構造的な類似性が観察されました.
結論:
- この構造は,タイプIIIのCRISPR-CasシステムによるRNAターゲティングと分裂のメカニズムを明らかにしています.
- この発見は,異なるCRISPR-Cas型には共通の進化的起源があることを示唆している.
- この研究は,細菌の適応免疫メカニズムに関する重要な洞察を提供します.
関連する概念動画
CRISPR
60.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
60.2K
CRISPR
19.0K
19.0K
CRISPR and crRNAs
20.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
20.4K
CRISPR/Cas9 Genome Editing
3.2K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
3.2K
The Antiviral System of Bacteria and Archaea: CRISPR
1.0K
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
1.0K
RNA Interference
28.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.9K

